Literature DB >> 30222437

Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements: A Randomized Study.

Helen W Sullivan1, Amie C O'Donoghue1, Kathryn J Aikin1.   

Abstract

BACKGROUND: Previous research demonstrated that providing qualitative and quantitative information in a "drug facts box" may help individuals understand prescription drug information in print-based direct-to-consumer advertisements. The authors sought to determine whether qualitative, quantitative, or a combination thereof best communicates benefit and risk information.
METHODS: To replicate and extend previous research, the authors used simple quantitative drug information. A randomized controlled study was conducted with 5067 Internet panelists with heartburn. Participants viewed a drug facts box with benefit and risk information that varied the presence or absence of qualitative summaries and absolute frequencies, percentages, and absolute differences. Measures included knowledge of drug benefits and risks, perceptions, and intentions.
RESULTS: Providing absolute frequencies and percentages most improved participants' drug knowledge and affected perceptions and intentions.
CONCLUSIONS: The study findings suggest that, for simple drug information, adding absolute frequencies and percentages to direct-to-consumer advertisements may benefit consumers. Absolute differences and qualitative labels may not be needed.

Entities:  

Keywords:  advertising; direct-to-consumer; prescription drugs; quantitative information; risk communication

Year:  2015        PMID: 30222437      PMCID: PMC7337975          DOI: 10.1177/2168479015572370

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  22 in total

1.  Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.

Authors:  J J Davis
Journal:  J Health Commun       Date:  2000 Oct-Dec

2.  More effective nutrition label formats are not necessarily preferred.

Authors:  A S Levy; S B Fein; R E Schucker
Journal:  J Am Diet Assoc       Date:  1992-10

Review 3.  Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations.

Authors:  Isaac M Lipkus
Journal:  Med Decis Making       Date:  2007-09-14       Impact factor: 2.583

4.  Getting to better prescription drug information.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  J Gen Intern Med       Date:  2012-12       Impact factor: 5.128

Review 5.  Communicating quantitative risks and benefits in promotional prescription drug labeling or print advertising.

Authors:  Suzanne L West; Linda B Squiers; Lauren McCormack; Brian G Southwell; Emily S Brouwer; Mahima Ashok; Linda Lux; Vanessa Boudewyns; Amie O'Donoghue; Helen W Sullivan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-02-26       Impact factor: 2.890

6.  Communicating data about the benefits and harms of treatment: a randomized trial.

Authors:  Steven Woloshin; Lisa M Schwartz
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

7.  The role of numeracy in understanding the benefit of screening mammography.

Authors:  L M Schwartz; S Woloshin; W C Black; H G Welch
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

Review 8.  Decision aids for people facing health treatment or screening decisions.

Authors:  Dawn Stacey; Carol L Bennett; Michael J Barry; Nananda F Col; Karen B Eden; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Anne Lyddiatt; France Légaré; Richard Thomson
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

9.  The value of benefit data in direct-to-consumer drug ads.

Authors:  Steven Woloshin; Lisa M Schwartz; H Gilbert Welch
Journal:  Health Aff (Millwood)       Date:  2004 Jan-Jun       Impact factor: 6.301

10.  The impact of the format of graphical presentation on health-related knowledge and treatment choices.

Authors:  Sarah T Hawley; Brian Zikmund-Fisher; Peter Ubel; Aleksandra Jancovic; Todd Lucas; Angela Fagerlin
Journal:  Patient Educ Couns       Date:  2008-08-27
View more
  9 in total

1.  The Effect of Including Quantitative Information on Multiple Endpoints in Direct-to-Consumer Prescription Drug Television Advertisements.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Molly Lynch; Mihaela Johnson; Christine Davis; Douglas J Rupert
Journal:  Med Decis Making       Date:  2019-10-04       Impact factor: 2.583

2.  Visual images of prescription drug benefits in direct-to-consumer television advertisements.

Authors:  Helen W Sullivan; Amie C O'Donoghue; Molly Lynch; Mihaela Johnson; Christine Davis; Jacqueline B Amoozegar; Douglas J Rupert
Journal:  Patient Educ Couns       Date:  2021-02-13

3.  Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe.

Authors:  Sabine Brosch; Anne-Marie de Ferran; Victoria Newbould; Diane Farkas; Marina Lengsavath; Phil Tregunno
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

4.  Assessing likelihood of product use for snus with modified-risk information among adult current cigarette smokers, former tobacco users, and never tobacco users.

Authors:  Karen Gerlach; Saul Shiffman; Deena Battista; Michael Polster; Geoffrey Curtin
Journal:  Addict Behav Rep       Date:  2019-07-26

5.  Details of risk-benefit communication in informed consent documents for phase I/II trials.

Authors:  Hannes Kahrass; Sabine Bossert; Christopher Schürmann; Daniel Strech
Journal:  Clin Trials       Date:  2020-11-24       Impact factor: 2.486

6.  Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan.

Authors:  Juan Ignacio Ruiz; Gagandeep Singh; McKenna Erck; Yimin Geng; Maria E Suarez-Almazor; Maria A Lopez-Olivo
Journal:  PLoS One       Date:  2022-10-10       Impact factor: 3.752

7.  Assessing comprehension and perceptions of modified-risk information for snus among adult current cigarette smokers, former tobacco users, and never tobacco users.

Authors:  Janine L Pillitteri; Saul Shiffman; Mark A Sembower; Michael R Polster; Geoffrey M Curtin
Journal:  Addict Behav Rep       Date:  2020-01-24

8.  Risk communication in tables versus text: a registered report randomized trial on 'fact boxes'.

Authors:  Cameron Brick; Michelle McDowell; Alexandra L J Freeman
Journal:  R Soc Open Sci       Date:  2020-03-25       Impact factor: 2.963

Review 9.  A systematic review of factors associated with side-effect expectations from medical interventions.

Authors:  Louise E Smith; Rebecca K Webster; G James Rubin
Journal:  Health Expect       Date:  2020-04-13       Impact factor: 3.377

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.